AGM-18366-64729
3 vaccinations
0 coded responses
8 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 890 / NV
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-02-17
Dose 2 — Pfizer-BioNTech
-
2021-02-18
Registered in v-safe
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-02-21
- 2021-08-18
-
2021-08-28
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-04
- 2021-11-27
- 2022-08-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-08-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.